Aurobindo Pharma Ltd
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 |
|---|---|---|---|
| Revenue | 3,280.13 | 3,041.40 | 3,000.64 |
| Operating Expense | 2,191.57 | 1,917.26 | 2,005.13 |
| Net Profit | 723.58 | 737.22 | 692.23 |
| Net Profit Margin | 22.06% | 24.24% | 23.07% |
| Earning Per Share | 12.58 | 12.75 | 11.92 |
| EBIDTA | 1,088.93 | 1,124.78 | 993.38 |
| Effective Tax Rate | 22.76% | 24.15% | 18.28% |
Particulars
Sep 2026
Revenue3,280.13
Operating Expense2,191.57
Net Profit723.58
Net Profit Margin22.06
Earning Per Share12.58
EBIDTA1,088.93
Effective Tax Rate22.76
